Login / Signup

Use of roxadustat (FG-4592) in ruxolitinib-treatment-related anemia of two myelofibrosis patients.

Kai DingZhaoyun LiuYue RenHui LiuWenhui Lei
Published in: Annals of hematology (2023)
Keyphrases
  • end stage renal disease
  • chronic kidney disease
  • ejection fraction
  • prognostic factors
  • peritoneal dialysis
  • combination therapy
  • drug induced